Clinical implications with tolvaptan on monitored bioimpedance-defined fluid status in patients with cirrhotic ascites: an observational study

BACKGROUND: Prognostic value or clinical implications of fluid status monitoring in liver cirrhosis are not fully elucidated. Tolvaptan, an orally available, selective vasopressin V2-receptor antagonist approved for hyponatremia in the United States and European Union. It is also used for cirrhotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiba, Shunsuke, Chu, Po-sung, Nakamoto, Nobuhiro, Yamataka, Karin, Taniki, Nobuhito, Ojiro, Keisuke, Yamaguchi, Akihiro, Morikawa, Rei, Yoshida, Aya, Ikura, Akihiko, Ebinuma, Hirotoshi, Saito, Hidetsugu, Kanai, Takanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059268/
https://www.ncbi.nlm.nih.gov/pubmed/32138675
http://dx.doi.org/10.1186/s12876-020-01205-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059268/
https://www.ncbi.nlm.nih.gov/pubmed/32138675
http://dx.doi.org/10.1186/s12876-020-01205-2

Ejemplares similares